This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Centre Hospitalier Regional Et Universitaire De Lille (Chru), Université De Lille 2 Droit Et Santé, Universite Du Littoral Cote D'opale. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 10 
1 out of 13 
1 out of 3 Years Active: 2018
Title: Charlotte Laloux - Innovator in Pharmaceutical Solutions
Introduction
Charlotte Laloux is a notable inventor based in Bourghelles, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. Her innovative approach has led to the development of a unique pharmaceutical solution that incorporates dopamine.
Latest Patents
Charlotte holds a patent for a pharmaceutical solution comprising dopamine for use in treating Parkinson's disease. This invention is particularly noteworthy as it ensures that the pharmaceutical solution is maintained under anaerobic conditions from its formulation to its administration. This method enhances the efficacy of the treatment and represents a significant advancement in the management of Parkinson's disease.
Career Highlights
Throughout her career, Charlotte has worked with esteemed institutions such as the Centre Hospitalier Regional Et Universitaire De Lille and the Université du Littoral Côte d'Opale. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Charlotte has collaborated with notable colleagues, including David Devos and Caroline Moreau. These partnerships have enriched her research and have been instrumental in the development of her innovative solutions.
Conclusion
Charlotte Laloux is a pioneering inventor whose work in pharmaceutical solutions is making a difference in the treatment of Parkinson's disease. Her dedication to innovation and collaboration continues to inspire advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile